A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista

First Page		Document Content
Date: 2013-05-06 11:02:45 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Lymphocytic leukemia B-cell chronic lymphocytic leukemia Fludarabine Leukemia Comorbidity Bendamustine Medicine Chemistry Oncology		A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 265,55 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.